Innoviva (INVA) Depreciation & Amortization (CF) (2010 - 2022)

Innoviva (INVA) posted Depreciation & Amortization (CF) of $12.5 million for Q3 2022, up 248.29% on a QoQ basis from $3.6 million in Q2 2022, and up 20.54% year-over-year from $10.4 million in Q3 2021.

Innoviva (INVA) Depreciation & Amortization (CF) (2010 - 2022) Analysis & Trends

Innoviva's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $12.5 million for Q3 2022.

  • Quarterly Depreciation & Amortization (CF) rose 20.54% year-over-year to $12.5 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $12.5 million (down 28.4% YoY) and the FY2021 annual result came in at $13.8 million, changed 0.06% from the prior year.
  • Depreciation & Amortization (CF) was $12.5 million for Q3 2022 at Innoviva, up from $3.6 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $12.5 million in Q3 2022 and bottomed at $3.3 million in Q3 2019.
  • A 5-year average of $4.4 million and a median of $3.5 million in 2018 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2019 — Depreciation & Amortization (CF) declined 4.27% — and 2021, when it soared 199.8%.
  • Innoviva's Depreciation & Amortization (CF) stood at $3.5 million in 2018, then grew by 0.17% to $3.5 million in 2019, then dropped by 0.46% to $3.5 million in 2020, then jumped by 200.06% to $10.4 million in 2021, then climbed by 20.54% to $12.5 million in 2022.
  • Business Quant data shows INVA's Depreciation & Amortization (CF) at $12.5 million in Q3 2022, $3.6 million in Q2 2022, and $3.5 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 12.51 Mn
Sep 30, 2022 12.51 Mn
Jun 30, 2022 3.59 Mn
Jun 30, 2022 3.59 Mn
Mar 31, 2022 3.50 Mn
Mar 31, 2022 3.50 Mn
Sep 30, 2021 10.38 Mn
Sep 30, 2021 10.38 Mn
Jun 30, 2021 3.46 Mn
Jun 30, 2021 3.46 Mn
Mar 31, 2021 3.46 Mn
Mar 31, 2021 3.46 Mn
Dec 31, 2020 3.46 Mn
Dec 31, 2020 3.46 Mn
Sep 30, 2020 3.46 Mn
Sep 30, 2020 3.46 Mn
Jun 30, 2020 3.46 Mn
Jun 30, 2020 3.46 Mn
Mar 31, 2020 3.46 Mn
Mar 31, 2020 3.46 Mn